. Author manuscript; available in PMC: 2012 Jan 1.

Published in final edited form as: J Drug Target. 2010 Mar 30;19(1):14–24. doi: 10.3109/10611861003733953

Table 2.

Quantification of Antitumor and Survival Data

Formulation	TGD^* (%)	MST^‡ (Days)	ILS^# (%)
PBS	-	47 ± 19	-
Dox 10 mg/kg	7	58 ± 21	21
PL-Dox 10 mg/kg	43	67 ± 19	42
F₃₃₅₀PL(0.03%)-Dox 10 mg/kg	43	55 ± 7	16
PL-Dox 20 mg/kg	64	55 ± 22	16
F₃₃₅₀PL(0.03%)-Dox 20 mg/kg	86	78 ± 12	65

TGD - tumor growth delay

^‡

MST - mean survival time

ILS - increase in life span